Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopausen AMS on Instagram

Menopausal Hormone Therapy (MHT) Patch discontinuation and shortages

30 May 2023

In Australia, all doses of Climara are being deleted from the market and there will be a reduction in supply until supply is exhausted.

Product
Composition
Date of deletion
Climara 25
25mcg oestradiol transdermal patch
31 Dec 2023
Climara 50
50mcg oestradiol transdermal patch
15 Nov 2023
Climara 75
75mcg oestradiol transdermal patch
15 Mar 2024
Climara 100
100mcg oestradiol transdermal patch
30 Sep 2023

Estalis Sequi 50/140 patches are currently unavailable and supply is expected to return by 26 May 2023. Estradot 100 is also currently unavailable and supply is expected to return by 30 June 2023.The recent shortages of Estraderm MX25, Provera and Tibolone have been resolved. Duavive is still unavailable.

The AMS Guide to MHT Equivalent Doses (Australia only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in Australia.

In New Zealand, there are also supply issues of Estradot 25, 50 and 75mcg and resupply is expected in July 2023. Estraderm and Estradiol TDM Mylan are available on Section 29. Details here

The AMS Guide to MHT Equivalent Doses (New Zealand only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in New Zealand.

Content created May 2023

Print Email

Search

Facebook Follow AMS on Linkedin Follow us on Twitter @amsmenopauseAMS on Instagram